← back to search
Ed Eggleton
Gilead Sciences (United States) · US
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, Sofosbuvir, Ledipasvir, Discontinuation, and Internal medicine.
h-index
—
citations
79
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older
Hepatology
2015
cited by
79
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Mani Subramanian
· National Heart Lung and Blood Institute
1
papers (2015–2015)
Sammy Saab
· UCLA Medical Center
1
papers (2015–2015)
Kris V. Kowdley
· Velocity Clinical Research (United States)
1
papers (2015–2015)
Yanni Zhu
· Jiangsu University
1
papers (2015–2015)
Masashi Mizokami
· National Center for Global Health and Medicine
1
papers (2015–2015)
Alessandra Mangia
· NIHR Birmingham Biomedical Research Centre
1
papers (2015–2015)
Phil Pang
· Gilead Sciences (United States)
1
papers (2015–2015)
Masao Omata
· University of Yamanashi Hospital
1
papers (2015–2015)
Steven Knox
· Gilead Sciences (United States)
1
papers (2015–2015)
Nezam H. Afdhal
· Harvard University
1
papers (2015–2015)
Sarah H. Park
· University of California, Los Angeles
1
papers (2015–2015)